Neighbourly Pharmacy (TSX:NBLY) - Hisse Senedi Fiyatı, Haberler ve Analizler

NBLY Stoklara Genel Bakış

Neighbourly Pharmacy Inc. owns and operates a chain of retail pharmacies in Canada.

NBLY temel anali̇z
Kar Tanesi Skoru
Değerleme	2/6
Gelecekteki Büyüme	1/6
Geçmiş Performans	0/6
Finansal Sağlık	3/6
Temettüler	0/6

Ödüller

Adil değer tahminimizden 30.1% daha düşük bir oranda işlem görüyor

Gelirin yılda 9.33% oranında artması öngörülüyor

Risk Analizi

Son 3 ayda önemli miktarda içeriden satış gerçekleşti

Neighbourly Pharmacy Inc. Rakipler

CareRx

TSX:CRRX

CA$111.1m

North West

TSX:NWC

CA$2.6b

Colabor Group

TSX:GCL

CA$108.1m

Ceres Global Ag

TSX:CRP

CA$108.9m

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Neighbourly Pharmacy
Tarihsel hisse senedi fiyatları
Güncel Hisse Fiyatı	CA$18.54
52 Haftanın En Yüksek Seviyesi	CA$23.00
52 Haftanın En Düşük Seviyesi	CA$12.05
Beta	0.29
11 Aylık Değişim	0.93%
3 Aylık Değişim	10.82%
1 Yıllık Değişim	-13.36%
33 Yıllık Değişim	n/a
5 Yıllık Değişim	n/a
Halka arzdan bu yana değişim	-17.56%

Son Haberler & Güncellemeler

Recent updates

Neighbourly Pharmacy (TSE:NBLY) Will Pay A Dividend Of CA$0.045

Aug 15

Estimating The Fair Value Of Neighbourly Pharmacy Inc. (TSE:NBLY)

Mar 22

Results: Neighbourly Pharmacy Inc. Delivered A Surprise Loss And Now Analysts Have New Forecasts

Feb 17

Calculating The Fair Value Of Neighbourly Pharmacy Inc. (TSE:NBLY)

Dec 09

Neighbourly Pharmacy's (TSE:NBLY) Robust Earnings Are Supported By Other Strong Factors

Aug 10

News Flash: Analysts Just Made A Substantial Upgrade To Their Neighbourly Pharmacy Inc. (TSE:NBLY) Forecasts

Mar 21

Is There An Opportunity With Neighbourly Pharmacy Inc.'s (TSE:NBLY) 48% Undervaluation?

Feb 27

Hissedar Getirileri

	NBLY	CA Consumer Retailing	CA Pazar
7D	0.05%	4.9%	2.2%
1Y	-13.4%	18.8%	24.3%

Getiri vs. Endüstri: NBLY geçen yıl % 18.8 oranında getiri sağlayan Canadian Consumer Retailing sektörünün gerisinde kaldı.

Getiri vs Piyasa: NBLY geçen yıl % 24.3 oranında getiri sağlayan Canadian Piyasasının altında performans gösterdi.

Fiyat Oynaklığı

Is NBLY's price volatile compared to industry and market?
NBLY volatility
NBLY Average Weekly Movement	5.0%
Consumer Retailing Industry Average Movement	3.2%
Market Average Movement	8.2%
10% most volatile stocks in CA Market	17.7%
10% least volatile stocks in CA Market	3.0%

İstikrarlı Hisse Senedi Fiyatı: NBLY son 3 ayda önemli bir fiyat oynaklığı yaşamadı.

Zaman İçindeki Volatilite: NBLY 'nin haftalık oynaklığı ( 5% ) son bir yıldır istikrarlı seyretti.

Şirket Hakkında

Kuruldu	Çalışanlar	CEO	Web sitesi
2015	3,648	Skip Bourdo	neighbourlypharmacy.ca

Neighbourly Pharmacy Inc. Temel Bilgiler Özeti

Neighbourly Pharmacy'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
NBLY temel i̇stati̇sti̇kler
Piyasa değeri	CA$840.40m
Kazançlar(TTM)	-CA$32.70m
Gelir(TTM)	CA$874.61m

1.0x

P/S Oranı

-25.6x

F/K Oranı

NBLY aşırı değerli mi?

Gerçeğe Uygun Değer ve değerleme analizine bakınız

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
NBLY gelir tablosu (TTM)
Gelir	CA$874.61m
Gelir Maliyeti	CA$527.56m
Brüt Kâr	CA$347.05m
Diğer Giderler	CA$379.76m
Kazançlar	-CA$32.70m

Son Raporlanan Kazançlar

Dec 30, 2023

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)	-0.72
Brüt Marj	39.68%
Net Kâr Marjı	-3.74%
Borç/Özkaynak Oranı	44.5%

NBLY uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

NBLY Stoklara Genel Bakış

Ödüller

Risk Analizi

Neighbourly Pharmacy Inc. Rakipler

TSX:CRRX

CA$111.1m

TSX:NWC

CA$2.6b

TSX:GCL

CA$108.1m

TSX:CRP

CA$108.9m

Fiyat Geçmişi ve Performans

Son Haberler & Güncellemeler

Neighbourly Pharmacy Inc. Announces CFO Changes

Neighbourly Pharmacy Inc. COM to Be Deleted from OTC Equity

Neighbourly Closes Go-Private Deal with Persistence

Third quarter 2024 earnings released: CA$0.11 loss per share (vs CA$0.20 loss in 3Q 2023)

Price target decreased by 12% to CA$18.80

Neighbourly Pharmacy Inc. Announces Executive Changes

Recent updates

Neighbourly Pharmacy Inc. Announces CFO Changes

Neighbourly Pharmacy Inc. COM to Be Deleted from OTC Equity

Neighbourly Closes Go-Private Deal with Persistence

Third quarter 2024 earnings released: CA$0.11 loss per share (vs CA$0.20 loss in 3Q 2023)

Price target decreased by 12% to CA$18.80

Neighbourly Pharmacy Inc. Announces Executive Changes

Neighbourly Pharmacy Inc. to Report Q3, 2024 Results on Feb 13, 2024

Upcoming dividend of CA$0.045 per share at 1.0% yield

Now 22% undervalued

Neighbourly Pharmacy Inc. to Report Q2, 2024 Results on Oct 24, 2023

PCP GP, L.P. entered into a letter of intent to acquire remaining all unknown minority stake in Neighbourly Pharmacy Inc. (TSX:NBLY) for CAD 470 million.

New major risk - Share price stability

Upcoming dividend of CA$0.045 per share at 1.1% yield

Neighbourly Pharmacy (TSE:NBLY) Will Pay A Dividend Of CA$0.045

Forecast breakeven date pushed back to 2025

First quarter 2024 earnings released: CA$0.27 loss per share (vs CA$0.029 loss in 1Q 2023)

Neighbourly Pharmacy Inc. to Report Q1, 2024 Results on Aug 01, 2023

Upcoming dividend of CA$0.045 per share at 1.1% yield

Independent Chairman of the Board recently bought CA$599k worth of stock

Neighbourly Pharmacy Inc. Announces Quarterly Dividend, Payable on August 3, 2023

Full year 2023 earnings released: CA$0.37 loss per share (vs CA$2.57 loss in FY 2022)

Neighbourly Pharmacy Inc. (TSX:NBLY) entered into a binding agreement to acquire Seven Pharmacies in Western Canada.

Neighbourly Pharmacy Inc. (TSX:NBLY) has entered into a binding agreement to acquire Three pharmacies in Ontario.

Neighbourly Pharmacy Inc., Annual General Meeting, Aug 01, 2023

Neighbourly Pharmacy Inc. to Report Q4, 2023 Results on Jun 08, 2023

Estimating The Fair Value Of Neighbourly Pharmacy Inc. (TSE:NBLY)

Upcoming dividend of CA$0.045 per share at 0.7% yield

CEO & Director recently bought CA$272k worth of stock

Forecast breakeven date pushed back to 2024

Results: Neighbourly Pharmacy Inc. Delivered A Surprise Loss And Now Analysts Have New Forecasts

Neighbourly Pharmacy Inc. Announces Quarterly Dividend, Payable on April 11, 2023

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus EPS estimates fall by 42%

Neighbourly Pharmacy Inc. to Report Q3, 2023 Results on Feb 14, 2023

Neighbourly Pharmacy Inc. Announces CEO Changes

Neighbourly Pharmacy Inc. (TSX:NBLY) completed the acquisition of Cloverdale Pharmacy Ltd. and Steveston Health Centre Ltd. from CloudMD Software & Services Inc. (TSXV:DOC)

Calculating The Fair Value Of Neighbourly Pharmacy Inc. (TSE:NBLY)

High number of new and inexperienced directors

Neighbourly Pharmacy Inc. Announces Quarterly Dividend, Payable on December 20, 2022

Consensus forecasts updated

Neighbourly Pharmacy Inc. (TSX:NBLY) acquired Assets of a Retail Pharmacy Located in Manitoba.

Neighbourly Pharmacy Inc. (TSX:NBLY) enter into a binding agreement to acquire Two Community Pharmacies Located in British Columbia.

Consensus forecasts updated

Now 21% undervalued after recent price drop

Neighbourly Pharmacy Inc. Appoints Billy Wong as CFO to Succeed Terri Smyth

Upcoming dividend of CA$0.045 per share

Neighbourly Pharmacy's (TSE:NBLY) Robust Earnings Are Supported By Other Strong Factors

First quarter 2023 earnings: EPS misses analyst expectations

Neighbourly Pharmacy Inc. Declares Dividend on Common Share for the First Quarter Ended June 18, 2022, Payable on September 27, 2022

Upcoming dividend of CA$0.045 per share

Neighbourly Pharmacy Inc. (TSX:NBLY) completed the acquisition of Rubicon Pharmacies Canada Inc.

Full year 2022 earnings: EPS misses analyst expectations

Price target decreased to CA$33.44

Neighbourly Pharmacy Inc. Announces Quarterly Dividend, Payable on August 18, 2022

Neighbourly Pharmacy Inc. to Report Q1, 2023 Results on Aug 02, 2022

Neighbourly Pharmacy Inc., Annual General Meeting, Aug 02, 2022

Neighbourly Pharmacy Inc. to Report Q4, 2022 Results on Jun 23, 2022

High number of new and inexperienced directors

Neighbourly Pharmacy Inc. announced that it has received CAD 138.163875 million in funding from PCP GP, L.P.